Fresenius SE KGaAXTER:FRE +0.43%67 Pretax Margin % is 9.92% as of Mar. 2026, which is 1% below its 10-year median of 10.00. GuruFocus rates XTER:FRE with a GF Score™ of 67/100 and a GF Value™ of €36.55 (Fairly Valued). The stock has 5 warning signs investors should review. Among 668 Healthcare Providers & Services companies, Fresenius SE KGaA ranks better than 69.91% on this metric.
The historical rank and industry rank for Fresenius SE KGaA's Pretax Margin % or its related term are showing as below:
XTER:FRE'
s Pretax Margin % Range Over the Past 10 Years
Min: 3.67 Med: 10 Max: 13.91
Current: 9.35
XTER:FRE's Pretax Margin % is ranked better than 69.91% of 668
companies
in the Healthcare Providers & Services industry
Industry Median: 3.97
vs XTER:FRE: 9.35
Fresenius SE KGaA (XTER:FRE) Pretax Margin % Explanation
The pretax margin, as know as pretax profit margin, is widely used to measure the operating efficiency of a company before deducting taxes.
The pretax margin is sometimes preferred over the net margin as tax expenditures can make profitability comparisons between companies misleading.
It is a useful tool to compare companies operating in the same sector and less effective when comparing companies from other sectors as each industry generally has different operating expenses and sales patterns.
The long term trend of the pretax margin is a good indicator of the competitiveness and health of the business.
Fresenius SE KGaA Pretax Margin % Related Terms
Fresenius SE KGaA Pretax Margin % Historical Data
* Premium members only.
The historical data trend for Fresenius SE KGaA's Pretax Margin % can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
XTER:FRE vs HCA, THC, DVA: Pretax Margin % Comparison
For the Medical Care Facilities subindustry, Fresenius SE KGaA's Pretax Margin %, along with its competitors' market caps and Pretax Margin % data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Fresenius SE KGaA Pretax Margin % vs Healthcare Providers & Services Industry
For the Healthcare Providers & Services industry and Healthcare sector, Fresenius SE KGaA's Pretax Margin % distribution charts can be found below:
* The bar in red indicates where Fresenius SE KGaA's Pretax Margin % falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Fresenius SE KGaA (XTER:FRE) has a Pretax Margin % of 9.92% as of Mar. 2026. Pre-Tax margin is the ratio of total pre-tax income to net sales. View historical data on Fresenius SE KGaA and its competitors. This is near median its historical median of 10.00. Over the past decade, Fresenius SE KGaA's Pretax Margin % has ranged from 3.67 to 13.91. According to the industry distribution chart, Fresenius SE KGaA ranks #201 out of 668 companies in the Healthcare Providers & Services industry, placing it in the top 30.1%.
Is Fresenius SE KGaA's Pretax Margin % too high?
Fresenius SE KGaA's current Pretax Margin % of 9.92% is near median its 10-year median of 10.00. Over the past 10 years, this metric has ranged from a low of 3.67 to a high of 13.91. The Healthcare Providers & Services industry median Pretax Margin % is 3.97. Fresenius SE KGaA's value of 9.92% is 149.9% above this industry median. Based on the distribution chart, Fresenius SE KGaA ranks #201 out of 668 companies in the Healthcare Providers & Services industry, which is above the industry midpoint. Overall, Fresenius SE KGaA has a GF Score™ of 67/100 and is considered Fairly Valued, reflecting its overall financial health beyond just this single metric.
How does Fresenius SE KGaA's Pretax Margin % compare to HCA and THC?
According to the Healthcare Providers & Services industry distribution chart, Fresenius SE KGaA ranks #201 out of 668 companies for Pretax Margin %. This puts Fresenius SE KGaA in the upper half of its industry. The industry median Pretax Margin % is 3.97. Fresenius SE KGaA's value of 9.92% is 149.9% above this benchmark. Historically, Fresenius SE KGaA's own Pretax Margin % has ranged from 3.67 to 13.91 over the past decade. While the company's 10-year median is 10.00 vs. the industry median of 3.97, Fresenius SE KGaA has consistently been above the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Pretax Margin % for a Healthcare Providers & Services company?
The median Pretax Margin % among Healthcare Providers & Services companies is 3.97, based on 668 companies in the industry. Companies in the top quartile (top 25%) have a Pretax Margin % significantly above this median, while those in the bottom quartile fall well below. However, Pretax Margin % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Fresenius SE KGaA's current Pretax Margin % of 9.92% is 149.9% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Pretax Margin % mean?
A high Pretax Margin % can signal that a stock is expensive relative to its fundamentals. Pre-Tax margin is the ratio of total pre-tax income to net sales. View historical data on Fresenius SE KGaA and its competitors. For the Healthcare Providers & Services industry, the median Pretax Margin % is 3.97 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Fresenius SE KGaA's current Pretax Margin % is 9.92%, which is near median its own 10-year median of 10.00. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Fresenius SE KGaA stock overvalued right now?
Based on GuruFocus' analysis, Fresenius SE KGaA (XTER:FRE) is currently considered Fairly Valued. The stock's GF Value™ is €36.55, compared to a current price of €40.07 — trading 9.6% above its estimated fair value. The current Pretax Margin % is 9.92%, which is near median its 10-year median of 10.00 and 149.9% above the Healthcare Providers & Services industry median of 3.97. Fresenius SE KGaA's overall GF Score™ is 67/100 with 5 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Pretax Margin % calculated?
Pretax Margin % is calculated from a company's financial statements. For Fresenius SE KGaA (XTER:FRE), the current Pretax Margin % is 9.92% as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Fresenius SE KGaA (XTER:FRE) Overvalued in 2026?
Based on GuruFocus' analysis, Fresenius SE KGaA stock appears to be overvalued.
The current stock price of €40.07 is trading 9.6% above its estimated GF Value™ of €36.55.
GuruFocus considers Fresenius SE KGaA to be Fairly Valued.
Key valuation signals for XTER:FRE:
Pretax Margin %: 9.92% (near median its 10-year median of 10.00)
GF Value™: €36.55 vs. price of €40.07 (9.6% above fair value)
Industry Position: 149.9% above the Healthcare Providers & Services median (#201 of 668)
No single metric tells the full story. See the XTER:FRE stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Fresenius is a healthcare holding company based in Germany. The company owns a minority stake in dialysis service provider and equipment manufacturer Fresenius Medical Care. The Kabi segment manufactures intravenous drugs, nutrition products, infusion and transfusion therapies, and related pumps. The Helios segment operates private hospitals primarily in Germany and Spain.
67GF Score
Get the complete analysis for XTER:FRE
Pretax Margin % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
XTER:FRE has been successfully added to your 
